Cellect Biotechnology logo

APOP - Cellect Biotechnology News Story

$3.17 0.0  0.3%

Last Trade - 22/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £5.28m
Enterprise Value £805k
Revenue £n/a
Position in Universe 6152nd / 6630

BRIEF-Cellect Biotechnology Commences Collaboration With XNK Therapeutics To Advance Novel Nk Cell-Based Therapies

Thu 29th October, 2020 12:37pm
Oct 29 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY LTD - COMMENCES COLLABORATION WITH
XNK
THERAPEUTICS TO ADVANCE NOVEL NK CELL-BASED THERAPIES
    * CELLECT BIOTECHNOLOGY - WILL HELP IMPROVE XNK
THERAPEUTICS'
TECHNOLOGY PLATFORM, FOR TARGETING CANCER ACROSS A WIDE RANGE OF
INDICATIONS
    * CELLECT BIOTECHNOLOGY LTD - EXPECTS TO EXPAND BUSINESS
ARRANGEMENT BASED ON OUTCOMES OF ONGOING STUDIES AT XNK
THERAPEUTICS

Source text for Eikon:  ID:nGNX4g9z54 
Further company coverage:  APOP.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.